Amphetamine is a strong central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity.
| FactSnippet No. 624,149 |
Amphetamine is a strong central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity.
| FactSnippet No. 624,149 |
Amphetamine properly refers to a specific chemical, the racemic free base, which is equal parts of the two enantiomers in their pure amine forms.
| FactSnippet No. 624,150 |
Amphetamine is used as an athletic performance enhancer and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant.
| FactSnippet No. 624,151 |
Amphetamine is used to treat attention deficit hyperactivity disorder, narcolepsy (a sleep disorder), and obesity, and is sometimes prescribed for its past medical indications, particularly for depression and chronic pain.
| FactSnippet No. 624,152 |
Amphetamine is used by some athletes for its psychological and athletic performance-enhancing effects, such as increased endurance and alertness; however, non-medical amphetamine use is prohibited at sporting events that are regulated by collegiate, national, and international anti-doping agencies.
| FactSnippet No. 624,153 |
Amphetamine improves endurance and reaction time primarily through reuptake inhibition and release of dopamine in the central nervous system.
| FactSnippet No. 624,154 |
Amphetamine has been shown to pass into breast milk, so the IPCS and the USFDA advise mothers to avoid breastfeeding when using it.
| FactSnippet No. 624,155 |
Amphetamine induces contraction in the urinary bladder sphincter, the muscle which controls urination, which can result in difficulty urinating.
| FactSnippet No. 624,156 |
Amphetamine has a slight analgesic effect and can enhance the pain relieving effects of opioids.
| FactSnippet No. 624,157 |
Amphetamine addiction is largely mediated through increased activation of dopamine receptors and NMDA receptors in the nucleus accumbens; magnesium ions inhibit NMDA receptors by blocking the receptor calcium channel.
| FactSnippet No. 624,158 |
Amphetamine has been identified as a potent full agonist of trace amine-associated receptor 1, a and G protein-coupled receptor (GPCR) discovered in 2001, which is important for regulation of brain monoamines.
| FactSnippet No. 624,159 |
Amphetamine is known to strongly induce cocaine- and amphetamine-regulated transcript gene expression, a neuropeptide involved in feeding behavior, stress, and reward, which induces observable increases in neuronal development and survival in vitro.
| FactSnippet No. 624,160 |
Amphetamine can enter the presynaptic neuron either through DAT or by diffusing across the neuronal membrane directly.
| FactSnippet No. 624,161 |
Amphetamine is a substrate for the presynaptic vesicular monoamine transporter, VMAT2.
| FactSnippet No. 624,162 |
Amphetamine affects serotonin via VMAT2 and, like norepinephrine, is thought to phosphorylate SERT via TAAR1.
| FactSnippet No. 624,163 |
Amphetamine induces the selective release of histamine from mast cells and efflux from histaminergic neurons through VMAT2.
| FactSnippet No. 624,164 |
Amphetamine is eliminated via the kidneys, with of the drug being excreted unchanged at normal urinary pH.
| FactSnippet No. 624,165 |
Amphetamine has a very similar structure and function to the endogenous trace amines, which are naturally occurring neuromodulator molecules produced in the human body and brain.
| FactSnippet No. 624,166 |
Amphetamine is a methyl homolog of the mammalian neurotransmitter phenethylamine with the chemical formula.
| FactSnippet No. 624,167 |
Amphetamine is the parent compound of its own structural class, which includes a number of psychoactive derivatives.
| FactSnippet No. 624,168 |
Amphetamine is frequently measured in urine or blood as part of a drug test for sports, employment, poisoning diagnostics, and forensics.
| FactSnippet No. 624,169 |
Amphetamine was first synthesized in 1887 in Germany by Romanian chemist Lazar Edeleanu who named it phenylisopropylamine; its stimulant effects remained unknown until 1927, when it was independently resynthesized by Gordon Alles and reported to have sympathomimetic properties.
| FactSnippet No. 624,170 |
Amphetamine had no medical use until late 1933, when Smith, Kline and French began selling it as an inhaler under the brand name Benzedrine as a decongestant.
| FactSnippet No. 624,171 |
Amphetamine is still illegally synthesized today in clandestine labs and sold on the black market, primarily in European countries.
| FactSnippet No. 624,172 |